Peptide nanomedicines for treatment of acute lung injury

Methods in Enzymology

Volumn 508, Issue , 2012, Pages 315-324

  Sadikot, Ruxana T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Acute lung injury; Drug delivery; Nanomedicine; Nanomicelles

Indexed keywords

DISTEAROYLPHOSPHATIDYLETHANOLAMINE; DOXORUBICIN; GLUCAGON LIKE PEPTIDE 1 [7-36] AMIDE; HEAT SHOCK PROTEIN 90; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROGOL; NANOPARTICLE; PEPTIDE DERIVATIVE; PHOSPHOLIPID DERIVATIVE; REACTIVE OXYGEN METABOLITE; STERICALLY STABILIZED PHOSPHOLIPID NANOMICELLE; TANESPIMYCIN; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG;

ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; AEROSOL; CRITICALLY ILL PATIENT; DRUG DEGRADATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG SAFETY; DRUG STABILITY; DRUG TARGETING; HUMAN; MICELLE; NANOMEDICINE; NANOTECHNOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STEREOSPECIFICITY;

EID: 84859026698     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-391860-4.00016-1     Document Type: Chapter

References (40)

1. I. Alana, J.C. Parker, V.A. Gault, P.R. Flatt, F.P. O'Harte, J.P. Malthouse, and C.M. Hewage NMR and alanine scan studies of glucose-dependent insulinotropic polypeptide in water J. Biol. Chem. 281 2006 16370 16376
2. S. Al-Sabah, and D. Donnelly The primary ligand-binding interaction at the GLP-1 receptor is via the putative helix of the peptide agonists Prot. Peptide Lett. 11 2004 9 14 (Pubitemid 38345498)
3. S. Azarrmi, W.H. Roa, and R. Loebenberg Targeted delivery of nanoparticles for the treatment of lung diseases Adv. Drug Deliv. Rev. 60 2008 863 875
4. M.M. Bailey, and C.J. Berkland Nanoparticle formulations in pulmonary drug delivery Med. Res. Rev. 29 2009 196 212
5. M. Beck-Broichsitter, J. Gauss, T. Gessler, W. Seeger, T. Kissel, and T. Schmehl Pulmonary targeting with biodegradable salbutamol-loaded nanoparticles J. Aerosol Med. Pulm. Drug Deliv. 23 1 2010 47 57
6. A. Bouchon, J. Dietrich, and M. Colonna Cutting edge: Inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes J. Immunol. 164 2000 4991
7. A. Bouchon, F. Facchetti, M.A. Weigand, and M. Colonna TREM-1 amplifies inflammation and is a crucial mediator of septic shock Nature 410 2001 1103
8. M. Bur, A. Henning, S. Hein, M. Schneider, and C.M. Lehr Inhalative nanomedicine - Opportunities and challenges Inhal. Toxicol. 21 Suppl. 1 2009 137 143
9. D.B. Buxton Nanomedicine for the management of lung and blood diseases Nanomedicine (London) 4 3 2009 331 339
10. P. Dames, B. Gleich, A. Flemmer, K. Hajek, N. Seidl, F. Wiekhorst, D. Eberbeck, I. Bittmann, C. Bergemann, T. Weyh, L. Trahms, and J. Rosenecker Targeted delivery of magnetic aerosol droplets to the lung Nat. Nanotechnol. 2 8 2007 495 499 (Pubitemid 47220067)
11. M. Foldvari, and M. Elsabahy Nanotechnology enables superior medical therapies Curr. Drug Deliv. 8 3 2011 225 226
12. T.D. Girard, and G.R. Bernard Mechanical ventilation in ARDS: a state-of-the-art review Chest. 131 3 2007 921-929 (Pubitemid 46446893)
13. B.Y. Kim, J.T. Rutka, and W.C. Chan Nanomedicine N. Engl. J. Med. 363 25 2010 2434 2443
14. C. Klingler, B.W. Müller, and H. Steckel Insulin-micro- and nanoparticles for pulmonary delivery Int. J. Pharm. 377 1-2 2009 173 179
15. O.M. Koo, I. Rubinstein, and H. Önyüksel Role of nanotechnology in targeted drug delivery and imaging: A concise review Nanomedicine 1 2005 193
16. S.B. Lim, I. Rubinstein, R.T. Sadikot, J.E. Artwohl, and H.A. Onyüksel Novel peptide nanomedicine against acute lung injury: GLP-1 in phospholipid micelles Pharm. Res. 28 3 2011 662 672
17. M. Liu, H. Zhang, and A.S. Slutsky Acute lung injury: a yellow card for engineered nanoparticles? J. Mol. Cell. Biol. 1 1 2009 6 7
18. H.M. Mansour, Y.S. Rhee, and X. Wu Nanomedicine in pulmonary delivery Int. J. Nanomedicine 4 2009 299 319
19. M.A. Matthay Treatment of acute lung injury: Clinical and experimental studies Proc. Am. Thorac. Soc. 5 2008 297
20. M.A. Matthay, and L.B. Ware The acute respiratory distress syndrome N. Engl. J. Med. 342 2000 1334
21. P. Mazzone Nanomedicine: Sniffing out lung cancer Nat. Nanotechnol. 4 10 2009 621 622
22. U. Pison, T. Welte, M. Giersig, and D.A. Groneberg Nanomedicine for respiratory diseases Eur. J. Pharmacol. 533 2006 341 350 (Pubitemid 43340025)
23. I. Roy, and N. Vij Nanodelivery in airway diseases: Challenges and therapeutic applications Nanomedicine 6 2 2010 237 244
24. G.D. Rubenfeld, and M.S. Herridge Epidemiology and outcomes of acute lung injury Chest 131 2007 554
25. I. Rubinstein, and H. Önyüksel Biocompatible, biodegradable and sterically stabilized phospholipid nanomicelles improve cryopreservation of oral keratinocytes: A preliminary investigation Int. J. Pharm. 338 2007 333
26. C. Rudolph, B. Gleich, and A.W. Flemmer Magnetic aerosol targeting of nanoparticles to cancer: Nanomagnetosols Methods Mol. Biol. 624 2010 267 280
27. E. Rytting, J. Nguyen, X. Wang, and T. Kissel Biodegradable polymeric nanocarriers for pulmonary drug delivery Exp. Opin. Drug Deliv. 5 2008 629 639 (Pubitemid 351998253)
28. R.T. Sadikot, and I. Rubinstein Long-acting, multi-targeted nanomedicine: Addressing unmet medical need in acute lung injury J. Biomed. Nanotechnol. 5 6 2009 614 619
29. R.T. Sadikot, J.W. Christman, and T.S. Blackwell Molecular targets for modulating lung inflammation and injury Curr. Drug Targets 5 2004 581
30. R.T. Sadikot, H. Zeng, M. Joo, M.B. Everhart, T.P. Sherrill, B. Li, D.S. Cheng, F.E. Yull, J.W. Christman, and T.S. Blackwell Targeted immunomodulation of the NF-kappaB pathway in airway epithelium impacts host defense against Pseudomonas aeruginosa J. Immunol. 176 2006 4923
31. R.T. Sadikot, P.S. Mohanty, H. Onyuksel, and I. Rubinstein Sterically stabilized phospholipid nanomicellar 17-allylaminodemethoxygeldanamycin inhibits lipopolysaccharide-induced activation of nuclear factor-κB in bone marrow-derived macrophages Am. J. Respir. Crit. Care Med. 177 Suppl. 2008 A75
32. R.T. Sadikot, S.B. Lim, H. Onyuksel, and I. Rubinstein TREM-1 self-associated with sterically stabilized phospholipid nanomicelles attenuates acute lung inflammation in mice Am. J. Respir. Crit. Care Med. 177 Suppl. 2008 A982
33. R.T. Sadikot, S. Lim, X. Wang, J.W. Christman, H. Onyuksel, and I. Rubinstein Salutary effects of nanomicellar GLP-1 administered after onset of LPS-induced acute lung inflammation in mice Am. J. Respir. Crit. Care Med. 179 Suppl. 2009 A5646
34. C. Schleh, B. Rothen-Rutishauser, and W.G. Kreyling The influence of pulmonary surfactant on nanoparticulate drug delivery systems Eur. J. Pharm. Biopharm. 77 3 2011 350 352
35. (R) ) for treating HIV infection and AIDS Cochrane Database Syst. Rev. 8 2009 CD005481
36. S. Singh Nanomedicine-nanoscale drugs and delivery systems J. Nanosci. Nanotechnol. 10 12 2010 7906 7918
37. M. Smola, T. Vandamme, and A. Sokolowski Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases Int. J. Nanomedicine 3 1 2008 1 19 (Pubitemid 351517072)
38. J.C. Sung, B.L. Pulliam, and D.A. Edwards Nanoparticles for drug delivery to the lungs Trends Biotechnol. 25 2007 563 570 (Pubitemid 350138179)
39. N.R. Yacobi, L. Demaio, J. Xie, S.F. Hamm-Alvarez, Z. Borok, K.J. Kim, and E.D. Crandall Polystyrene nanoparticle trafficking across alveolar epithelium Nanomedicine 4 2 2008 139 145
40. W. Yang, J.I. Peters, and R.O. Williams III Inhaled nanoparticles - A current review Int. J. Pharm. 356 2008 239 247